Lansac Emmanuel, Di Centa Isabelle, Danial Pichoy, Bouchot Olivier, Arnaud-Crozat Eric, Hacini Rachid, Doguet Fabien, Demaria Roland, Verhoye Jean Philippe, Jouan Jerome, Chatel Didier, Lopez Stephane, Folliguet Thierry, Leprince Pascal, Langanay Thierry, Latremouille Christian, Fayad Georges, Fleury Jean Philippe, Monin Jean Luc, Mankoubi Leila, Noghin Milena, Berrebi Alain, Pousset Sarah, Laubriet-Jazayeri Aline, Lafourcade Alexandre, Marcault Estelle, Kindo Michel, Payot Laurent, Bergoend Eric, Hoffart Cecile Jourdain, Debauchez Mathieu, Tubach Florence
Department of Cardiac Surgery, CHU Pitié Salpetriere, Paris, France.
Department of Vascular Surgery, Hopital Foch, Suresnes, France.
Eur J Cardiothorac Surg. 2022 Jul 11;62(2). doi: 10.1093/ejcts/ezac283.
Despite growing evidence that aortic valve repair improves long-term patient outcomes and quality of life, aortic valves are mostly replaced. We evaluate the effect of aortic valve repair versus replacement in patients with dystrophic aortic root aneurysm up to 4 years.
The multicentric CAVIAAR (Conservation Aortique Valvulaire dans les Insuffisances Aortiques et les Anévrismes de la Racine aortique) prospective cohort study enrolled 261 patients: 130 underwent standardized aortic valve repair (REPAIR) consisting of remodelling root repair with expansible aortic ring annuloplasty, and 131 received mechanical composite valve and graft replacement (REPLACE). Primary outcome was a composite criterion of mortality, reoperation, thromboembolic or major bleeding events, endocarditis or operating site infections, pacemaker implantation and heart failure, analysed with propensity score-weighted Cox model analysis. Secondary outcomes included major adverse valve-related events and components of primary outcome.
The mean age was 56.1 years, and valve was bicuspid in 115 patients (44.7%). Up to 4 years, REPAIR did not significantly differ from REPLACE in terms of primary outcome [Hazard Ratio (HR) 0.66 (0.39; 1.12)] but showed significantly less valve-related deaths (HR 0.09 [0.02; 0.34]) and major bleeding events (HR 0.37 [0.16; 0.85]) without an increased risk of valve-related reoperation (HR 2.10 [0.64; 6.96]). When accounting for the occurrence of multiple events in a single patient, the REPAIR group had half the occurrence of major adverse valve-related events (HR 0.51 [0.31; 0.86]).
Although the primary outcome did not significantly differ between the REPAIR and REPLACE groups, the trend is in favour of REPAIR by a significant reduction of valve-related deaths and major bleeding events. Long-term follow-up beyond 4 years is needed to confirm these findings.
尽管越来越多的证据表明主动脉瓣修复可改善患者的长期预后和生活质量,但主动脉瓣大多还是被置换。我们评估了主动脉瓣修复与置换对患有营养不良性主动脉根部瘤患者长达4年的影响。
多中心CAVIAAR(主动脉瓣反流和主动脉根部瘤中的主动脉瓣保留)前瞻性队列研究纳入了261例患者:130例接受了标准化主动脉瓣修复(修复组),包括使用可扩张主动脉环成形术进行根部重塑修复;131例接受了机械复合瓣膜和移植物置换(置换组)。主要结局是一个综合标准,包括死亡率、再次手术、血栓栓塞或大出血事件、心内膜炎或手术部位感染、起搏器植入和心力衰竭,采用倾向评分加权Cox模型分析。次要结局包括主要的瓣膜相关不良事件和主要结局的组成部分。
平均年龄为56.1岁,115例患者(44.7%)的瓣膜为二叶式。长达4年时,修复组和置换组在主要结局方面无显著差异[风险比(HR)0.66(0.39;1.12)],但瓣膜相关死亡(HR 0.09[0.02;0.34])和大出血事件(HR 0.37[0.16;0.85])显著减少,且瓣膜相关再次手术风险未增加(HR 2.10[0.64;6.96])。当考虑单个患者发生多种事件的情况时,修复组主要瓣膜相关不良事件的发生率为置换组的一半(HR 0.51[0.31;0.86])。
尽管修复组和置换组在主要结局方面无显著差异,但趋势是修复组因瓣膜相关死亡和大出血事件显著减少而更具优势。需要超过4年的长期随访来证实这些发现。